Selected research
Market Outlook & Growth Opportunities
Global Personal Gene Sequencing Service Market Outlook and Growth Opportunities 2026
Market perspective
The global Personal Gene Sequencing Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Personal Gene Sequencing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Personal Gene Sequencing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Personal Gene Sequencing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Personal Gene Sequencing Service market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Personal Gene Sequencing Service market include Illumina, BGI Genomics Co.,Ltd., Agilent Technologies, Macrogen, Pacific Biosciences, 10x Genomics, QIAGEN, GEEWIZ and MACROGEN, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Personal Gene Sequencing Service market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Personal Gene Sequencing Service and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Personal Gene Sequencing Service revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Personal Gene Sequencing Service market.
Personal Gene Sequencing Service Segment by Company
Illumina
BGI Genomics Co.,Ltd.
Agilent Technologies
Macrogen
Pacific Biosciences
10x Genomics
QIAGEN
GEEWIZ
MACROGEN
WeGene
23andMe
Mega Genomics
Berry Genomics
CapitalBio Corp.
Annaroad Gene Technology(Beijing)Co., Ltd.
Personal Gene Sequencing Service Segment by Type
Prenatal Screening
Detection of Microorganism
Screening for Genetic Diseases
Tumor Diagnosis and Treatment
Personal Gene Sequencing Service Segment by Application
Gene Chip Technology
PCR
High-throughput Sequencing
Personal Gene Sequencing Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Personal Gene Sequencing Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Personal Gene Sequencing Service key companies, revenue, market share, and recent developments.
3. To split the Personal Gene Sequencing Service breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Personal Gene Sequencing Service market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Personal Gene Sequencing Service significant trends, drivers, influence factors in global and regions.
6. To analyze Personal Gene Sequencing Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Personal Gene Sequencing Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Personal Gene Sequencing Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Personal Gene Sequencing Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Personal Gene Sequencing Service industry.
Chapter 3: Detailed analysis of Personal Gene Sequencing Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Personal Gene Sequencing Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Personal Gene Sequencing Service in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Prenatal Screening
- Detection of Microorganism
- Screening for Genetic Diseases
- Tumor Diagnosis and Treatment
Applications
- Gene Chip Technology
- PCR
- High-throughput Sequencing
Companies covered
- Illumina
- BGI Genomics Co.,Ltd.
- Agilent Technologies
- Macrogen
- Pacific Biosciences
- 10x Genomics
- QIAGEN
- GEEWIZ
- MACROGEN
- WeGene
- 23andMe
- Mega Genomics
- Berry Genomics
- CapitalBio Corp.
- Annaroad Gene Technology(Beijing)Co., Ltd.
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Personal Gene Sequencing Service Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Personal Gene Sequencing Service Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Personal Gene Sequencing Service Market Dynamics
- 2.1 Personal Gene Sequencing Service Industry Trends
- 2.2 Personal Gene Sequencing Service Industry Drivers
- 2.3 Personal Gene Sequencing Service Industry Opportunities and Challenges
- 2.4 Personal Gene Sequencing Service Industry Restraints
3 Personal Gene Sequencing Service Market by Company
- 3.1 Global Personal Gene Sequencing Service Company Revenue Ranking in 2025
- 3.2 Global Personal Gene Sequencing Service Revenue by Company (2021-2026)
- 3.3 Global Personal Gene Sequencing Service Company Ranking (2024-2026)
- 3.4 Global Personal Gene Sequencing Service Company Manufacturing Base and Headquarters
- 3.5 Global Personal Gene Sequencing Service Company Product Type and Application
- 3.6 Global Personal Gene Sequencing Service Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Personal Gene Sequencing Service Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Personal Gene Sequencing Service Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Personal Gene Sequencing Service Market by Type
- 4.1 Personal Gene Sequencing Service Type Introduction
- 4.1.1 Prenatal Screening
- 4.1.2 Detection of Microorganism
- 4.1.3 Screening for Genetic Diseases
- 4.1.4 Tumor Diagnosis and Treatment
- 4.2 Global Personal Gene Sequencing Service Sales Value by Type
- 4.2.1 Global Personal Gene Sequencing Service Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Personal Gene Sequencing Service Sales Value by Type (2021-2032)
- 4.2.3 Global Personal Gene Sequencing Service Sales Value Share by Type (2021-2032)
5 Personal Gene Sequencing Service Market by Application
- 5.1 Personal Gene Sequencing Service Application Introduction
- 5.1.1 Gene Chip Technology
- 5.1.2 PCR
- 5.1.3 High-throughput Sequencing
- 5.2 Global Personal Gene Sequencing Service Sales Value by Application
- 5.2.1 Global Personal Gene Sequencing Service Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Personal Gene Sequencing Service Sales Value by Application (2021-2032)
- 5.2.3 Global Personal Gene Sequencing Service Sales Value Share by Application (2021-2032)
6 Personal Gene Sequencing Service Regional Value Analysis
- 6.1 Global Personal Gene Sequencing Service Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Personal Gene Sequencing Service Sales Value by Region (2021-2032)
- 6.2.1 Global Personal Gene Sequencing Service Sales Value by Region: 2021-2026
- 6.2.2 Global Personal Gene Sequencing Service Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Personal Gene Sequencing Service Sales Value (2021-2032)
- 6.3.2 North America Personal Gene Sequencing Service Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Personal Gene Sequencing Service Sales Value (2021-2032)
- 6.4.2 Europe Personal Gene Sequencing Service Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Personal Gene Sequencing Service Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Personal Gene Sequencing Service Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Personal Gene Sequencing Service Sales Value (2021-2032)
- 6.6.2 South America Personal Gene Sequencing Service Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Personal Gene Sequencing Service Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Personal Gene Sequencing Service Sales Value Share by Country, 2025 VS 2032
7 Personal Gene Sequencing Service Country-level Value Analysis
- 7.1 Global Personal Gene Sequencing Service Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Personal Gene Sequencing Service Sales Value by Country (2021-2032)
- 7.2.1 Global Personal Gene Sequencing Service Sales Value by Country (2021-2026)
- 7.2.2 Global Personal Gene Sequencing Service Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Personal Gene Sequencing Service Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Personal Gene Sequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Personal Gene Sequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Personal Gene Sequencing Service Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Personal Gene Sequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Personal Gene Sequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Personal Gene Sequencing Service Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Personal Gene Sequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Personal Gene Sequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Personal Gene Sequencing Service Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Personal Gene Sequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Personal Gene Sequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Personal Gene Sequencing Service Sales Value Growth Rate (2021-2032)
- 7.7.2 France Personal Gene Sequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Personal Gene Sequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Personal Gene Sequencing Service Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Personal Gene Sequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Personal Gene Sequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Personal Gene Sequencing Service Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Personal Gene Sequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Personal Gene Sequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Personal Gene Sequencing Service Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Personal Gene Sequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Personal Gene Sequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Personal Gene Sequencing Service Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Personal Gene Sequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Personal Gene Sequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Personal Gene Sequencing Service Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Personal Gene Sequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Personal Gene Sequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Personal Gene Sequencing Service Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Personal Gene Sequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Personal Gene Sequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Personal Gene Sequencing Service Sales Value Growth Rate (2021-2032)
- 7.14.2 China Personal Gene Sequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Personal Gene Sequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Personal Gene Sequencing Service Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Personal Gene Sequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Personal Gene Sequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Personal Gene Sequencing Service Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Personal Gene Sequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Personal Gene Sequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Personal Gene Sequencing Service Sales Value Growth Rate (2021-2032)
- 7.17.2 India Personal Gene Sequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Personal Gene Sequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Personal Gene Sequencing Service Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Personal Gene Sequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Personal Gene Sequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Personal Gene Sequencing Service Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Personal Gene Sequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Personal Gene Sequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Personal Gene Sequencing Service Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Personal Gene Sequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Personal Gene Sequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Personal Gene Sequencing Service Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Personal Gene Sequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Personal Gene Sequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Personal Gene Sequencing Service Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Personal Gene Sequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Personal Gene Sequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Personal Gene Sequencing Service Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Personal Gene Sequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Personal Gene Sequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Personal Gene Sequencing Service Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Personal Gene Sequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Personal Gene Sequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Personal Gene Sequencing Service Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Personal Gene Sequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Personal Gene Sequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Personal Gene Sequencing Service Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Personal Gene Sequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Personal Gene Sequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Personal Gene Sequencing Service Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Personal Gene Sequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Personal Gene Sequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Personal Gene Sequencing Service Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Personal Gene Sequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Personal Gene Sequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Personal Gene Sequencing Service Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Personal Gene Sequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Personal Gene Sequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Personal Gene Sequencing Service Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Personal Gene Sequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Personal Gene Sequencing Service Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Illumina
- 8.1.1 Illumina Company Information
- 8.1.2 Illumina Business Overview
- 8.1.3 Illumina Personal Gene Sequencing Service Revenue and Gross Margin (2021-2026)
- 8.1.4 Illumina Personal Gene Sequencing Service Product Portfolio
- 8.1.5 Illumina Recent Developments
- 8.2 BGI Genomics Co.,Ltd.
- 8.2.1 BGI Genomics Co.,Ltd. Company Information
- 8.2.2 BGI Genomics Co.,Ltd. Business Overview
- 8.2.3 BGI Genomics Co.,Ltd. Personal Gene Sequencing Service Revenue and Gross Margin (2021-2026)
- 8.2.4 BGI Genomics Co.,Ltd. Personal Gene Sequencing Service Product Portfolio
- 8.2.5 BGI Genomics Co.,Ltd. Recent Developments
- 8.3 Agilent Technologies
- 8.3.1 Agilent Technologies Company Information
- 8.3.2 Agilent Technologies Business Overview
- 8.3.3 Agilent Technologies Personal Gene Sequencing Service Revenue and Gross Margin (2021-2026)
- 8.3.4 Agilent Technologies Personal Gene Sequencing Service Product Portfolio
- 8.3.5 Agilent Technologies Recent Developments
- 8.4 Macrogen
- 8.4.1 Macrogen Company Information
- 8.4.2 Macrogen Business Overview
- 8.4.3 Macrogen Personal Gene Sequencing Service Revenue and Gross Margin (2021-2026)
- 8.4.4 Macrogen Personal Gene Sequencing Service Product Portfolio
- 8.4.5 Macrogen Recent Developments
- 8.5 Pacific Biosciences
- 8.5.1 Pacific Biosciences Company Information
- 8.5.2 Pacific Biosciences Business Overview
- 8.5.3 Pacific Biosciences Personal Gene Sequencing Service Revenue and Gross Margin (2021-2026)
- 8.5.4 Pacific Biosciences Personal Gene Sequencing Service Product Portfolio
- 8.5.5 Pacific Biosciences Recent Developments
- 8.6 10x Genomics
- 8.6.1 10x Genomics Company Information
- 8.6.2 10x Genomics Business Overview
- 8.6.3 10x Genomics Personal Gene Sequencing Service Revenue and Gross Margin (2021-2026)
- 8.6.4 10x Genomics Personal Gene Sequencing Service Product Portfolio
- 8.6.5 10x Genomics Recent Developments
- 8.7 QIAGEN
- 8.7.1 QIAGEN Company Information
- 8.7.2 QIAGEN Business Overview
- 8.7.3 QIAGEN Personal Gene Sequencing Service Revenue and Gross Margin (2021-2026)
- 8.7.4 QIAGEN Personal Gene Sequencing Service Product Portfolio
- 8.7.5 QIAGEN Recent Developments
- 8.8 GEEWIZ
- 8.8.1 GEEWIZ Company Information
- 8.8.2 GEEWIZ Business Overview
- 8.8.3 GEEWIZ Personal Gene Sequencing Service Revenue and Gross Margin (2021-2026)
- 8.8.4 GEEWIZ Personal Gene Sequencing Service Product Portfolio
- 8.8.5 GEEWIZ Recent Developments
- 8.9 MACROGEN
- 8.9.1 MACROGEN Company Information
- 8.9.2 MACROGEN Business Overview
- 8.9.3 MACROGEN Personal Gene Sequencing Service Revenue and Gross Margin (2021-2026)
- 8.9.4 MACROGEN Personal Gene Sequencing Service Product Portfolio
- 8.9.5 MACROGEN Recent Developments
- 8.10 WeGene
- 8.10.1 WeGene Company Information
- 8.10.2 WeGene Business Overview
- 8.10.3 WeGene Personal Gene Sequencing Service Revenue and Gross Margin (2021-2026)
- 8.10.4 WeGene Personal Gene Sequencing Service Product Portfolio
- 8.10.5 WeGene Recent Developments
- 8.11 23andMe
- 8.11.1 23andMe Company Information
- 8.11.2 23andMe Business Overview
- 8.11.3 23andMe Personal Gene Sequencing Service Revenue and Gross Margin (2021-2026)
- 8.11.4 23andMe Personal Gene Sequencing Service Product Portfolio
- 8.11.5 23andMe Recent Developments
- 8.12 Mega Genomics
- 8.12.1 Mega Genomics Company Information
- 8.12.2 Mega Genomics Business Overview
- 8.12.3 Mega Genomics Personal Gene Sequencing Service Revenue and Gross Margin (2021-2026)
- 8.12.4 Mega Genomics Personal Gene Sequencing Service Product Portfolio
- 8.12.5 Mega Genomics Recent Developments
- 8.13 Berry Genomics
- 8.13.1 Berry Genomics Company Information
- 8.13.2 Berry Genomics Business Overview
- 8.13.3 Berry Genomics Personal Gene Sequencing Service Revenue and Gross Margin (2021-2026)
- 8.13.4 Berry Genomics Personal Gene Sequencing Service Product Portfolio
- 8.13.5 Berry Genomics Recent Developments
- 8.14 CapitalBio Corp.
- 8.14.1 CapitalBio Corp. Company Information
- 8.14.2 CapitalBio Corp. Business Overview
- 8.14.3 CapitalBio Corp. Personal Gene Sequencing Service Revenue and Gross Margin (2021-2026)
- 8.14.4 CapitalBio Corp. Personal Gene Sequencing Service Product Portfolio
- 8.14.5 CapitalBio Corp. Recent Developments
- 8.15 Annaroad Gene Technology(Beijing)Co., Ltd.
- 8.15.1 Annaroad Gene Technology(Beijing)Co., Ltd. Company Information
- 8.15.2 Annaroad Gene Technology(Beijing)Co., Ltd. Business Overview
- 8.15.3 Annaroad Gene Technology(Beijing)Co., Ltd. Personal Gene Sequencing Service Revenue and Gross Margin (2021-2026)
- 8.15.4 Annaroad Gene Technology(Beijing)Co., Ltd. Personal Gene Sequencing Service Product Portfolio
- 8.15.5 Annaroad Gene Technology(Beijing)Co., Ltd. Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst